Dynamics of leptin, insulin resistance, parathyroid hormone, 25(OH)D in the implementation of the eras-protocol in patients of surgical profile

Authors

DOI:

https://doi.org/10.15587/2519-4798.2020.213824

Keywords:

sarcopenic obesity, vitamin D, ERAS-program, cholecalciferol, leptin, quality of life, prognosis

Abstract

The aim: to increase the effectiveness of treatment of patients of surgical profile with overweight by developing algorithms for perioperative intensive care for the successful implementation of the ERAS protocol.

Material and methods. The basis of this study is the analysis of the results of a comprehensive clinical and instrumental dynamic examination of 122 patients with surgical herniological profile for a period of 1 day to 1 month from the date of surgery. The study included patients with ventral hernias of the anterior abdominal wall, which were determined by the SWR classification. The conditions for admission to the study under the conditions of inclusion were a fence 10 days before surgery to determine the analysis of vitamin D concentration. 3 groups of patients were identified (control, with addition to the protocol of treatment of cholecalciferol, with addition to the protocol of treatment of cholecalciferol and a solution of D-fructose-1,6-diphosphate sodium salt of hydrate). Determined the type of fat distribution, index of visceral obesity, triglycerides, high-density lipoprotein, leptin, fasting glucose, endogenous insulin, calculated the index of HOMA. Parametric statistics methods were used to process the obtained data.

Results. In the vast majority of overweight patients (90 %) the abdominal type of fat distribution with the presence of visceral index obesity was determined. At the time of screening, the concentration of leptin in the blood of all studied patients exceeded the upper limit of normal by almost 4 times. The absence of a probable connection between the level of 25 (OH) D and leptin was determined, which confirms the presence of obesity due to reduced muscle mass and impaired energy metabolism, the presence of a relationship between the level of 25 (OH) D, HOMA, concentration of parathyroid hormone in the blood.

Conclusions. Implementation of a planned surgical profile in overweight patients at the screening stage 10 days before surgery to determine the level of 25 (OH) D in the blood is a key point in deciding the possibility of conducting the perioperative period according to the ERAS program. Additional purpose to its classical protocol of cholecalciferol and solution of D-fructose-1,6-diphosphate sodium salt of hydrate increases the quality of motor activity of patients after surgery, increases their adaptive potential by restoring lost muscle function. The optimized classical algorithm of the ERAS-program significantly (p <0.05) improved the quality of life in the long term (30 days after surgery), such as physical functioning, general health, viability scale, mental health (SF-36 scale) and decreased body mass index

Author Biographies

Hlib Diachenko, Kharkiv National Medical University Nauky ave., 4, Kharkiv, Ukraine, 61022

Assistant

Department of Emergency Medicine, Anesthesiology and Intensive Care

Yuliya Volkova, Kharkiv National Medical University Nauky ave., 4, Kharkiv, Ukraine, 61022

MD, Professor, Head of Department

Department of Emergency Medicine, Anesthesiology and Intensive Care

References

  1. Gil, Á., Plaza-Diaz, J., Mesa, M. D. (2018). Vitamin D: Classic and Novel Actions. Annals of Nutrition and Metabolism, 72 (2), 87–95. doi: http://doi.org/10.1159/000486536
  2. Gunton, J. E., Girgis, C. M. (2018). Vitamin D and muscle. Bone Reports, 8, 163–167. doi: http://doi.org/10.1016/j.bonr.2018.04.004
  3. Srinath, K. M., Shashidhara, K. C., Reddy, G. R., Basavegowda, M. (2016). Pattern of vitamin D status in prediabetic individuals: a case control study at tertiary hospital in South India. International Journal of Research in Medical Sciences, 4, 1010–1015. doi: http://doi.org/10.18203/2320-6012.ijrms20160706
  4. Dzik, K. P., Kaczor, J. J. (2019). Mechanisms of vitamin D on skeletal muscle function: oxidative stress, energy metabolism and anabolic state. European Journal of Applied Physiology, 119 (4), 825–839. doi: http://doi.org/10.1007/s00421-019-04104-x
  5. Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C. et. al. (2018). Obesity, Metabolic Syndrome, and Musculoskeletal Disease: Common Inflammatory Pathways Suggest a Central Role for Loss of Muscle Integrity. Frontiers in Physiology, 9. doi: http://doi.org/10.3389/fphys.2018.00112
  6. Wacker, M., Holick, M. F. (2013). Sunlight and Vitamin D. Dermato-Endocrinology, 5 (1), 51–108. doi: http://doi.org/10.4161/derm.24494
  7. Richard, A., Rohrmann, S., Quack Lötscher, K. (2017). Prevalence of Vitamin D Deficiency and Its Associations with Skin Color in Pregnant Women in the First Trimester in a Sample from Switzerland. Nutrients, 9 (3), 260. doi: http://doi.org/10.3390/nu9030260
  8. Elder, D. H. J., Singh, J. S. S., Levin, D., Donnelly, L. A., Choy, A.-M., George, J. et. al. (2015). Mean HbA1cand mortality in diabetic individuals with heart failure: a population cohort study. European Journal of Heart Failure, 18 (1), 94–102. doi: http://doi.org/10.1002/ejhf.455
  9. Pereira-Santos, M., Costa, P. R. F., Santos, C. A. S. T., Santos, D. B., Assis, A. M. O. (2016). Obesity and vitamin D deficiency: is there an association? Obesity Reviews, 17 (5), 484. doi: http://doi.org/10.1111/obr.12393
  10. Srikanth, P., Chun, R. F., Hewison, M., Adams, J. S., Bouillon, R. et. al. (2016). Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men. Osteoporosis International, 27 (7), 2291–2300. doi: http://doi.org/10.1007/s00198-016-3537-3
  11. Zhai, H.-L., Wang, N.-J., Han, B., Li, Q., Chen, Y., Zhu, C.-F. et. al. (2016). Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)). British Journal of Nutrition, 115 (8), 1352–1359. doi: http://doi.org/10.1017/s0007114516000386
  12. Beilfuss, A., Sowa, J.-P., Sydor, S., Beste, M., Bechmann, L. P., Schlattjan, M. et. al. (2014). Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut, 64 (5), 791–799. doi: http://doi.org/10.1136/gutjnl-2014-307024
  13. Druzhilov, M. A., Beteleva, Y. E., Kuznetsova, T. Y. (2014). Epicardial adipose tissue thickness – an alternative to waist circumference as a stand-alone or secondary main criterion in metabolic syndrome diagnostics? Russian Journal of Cardiology, 3, 76–81. doi: http://doi.org/10.15829/1560-4071-2014-3-76-81
  14. Bowes, C. D., Lien, L. F., Butler, J. (2019). Clinical aspects of heart failure in individuals with diabetes. Diabetologia, 62 (9), 1529–1538. doi: http://doi.org/10.1007/s00125-019-4958-2
  15. Joubert, M., Manrique, A., Cariou, B., Prieur, X. (2019). Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathways. Diabetes & Metabolism, 45 (3), 238–247. doi: http://doi.org/10.1016/j.diabet.2018.07.003
  16. Bottle, A., Kim, D., Hayhoe, B., Majeed, A., Aylin, P., Clegg, A., Cowie, M. R. (2019). Frailty and co-morbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England. Age and Ageing, 48 (3), 347–354. doi: http://doi.org/10.1093/ageing/afy194
  17. Leung, P. (2016). The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. Nutrients, 8 (3), 147. doi: http://doi.org/10.3390/nu8030147
  18. McMullan, C. J., Borgi, L., Curhan, G. C., Fisher, N., Forman, J. P. (2017). The effect of vitamin D on renin–angiotensin system activation and blood pressure. Journal of Hypertension, 35 (4), 822–829. doi: http://doi.org/10.1097/hjh.0000000000001220
  19. Ye, Z., Sharp, S. J., Burgess, S., Scott, R. A., Imamura, F., Langenberg, C. et. al. (2015). Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. The Lancet Diabetes & Endocrinology, 3 (1), 35–42. doi: http://doi.org/10.1016/s2213-8587(14)70184-6
  20. Flier, J. S., Maratos-Flier, E. (2017). Leptin’s Physiologic Role: Does the Emperor of Energy Balance Have No Clothes? Cell Metabolism, 26 (1), 24–26. doi: http://doi.org/10.1016/j.cmet.2017.05.013
  21. Al Qarni, A. A., Joatar, F. E., Das, N., Awad, M., Eltayeb, M., Al-Zubair, A. G. et. al. (2017). Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects. Endocrinology and Metabolism, 32 (2), 230–240. doi: http://doi.org/10.3803/enm.2017.32.2.230
  22. Cohen, P., Spiegelman, B. M. (2016). Cell biology of fat storage. Molecular Biology of the Cell, 27 (16), 2523–2527. doi: http://doi.org/10.1091/mbc.e15-10-0749
  23. Esfahani, M., Movahedian, A., Baranchi, M., Goodarzi, M. T. (2015). Adiponectin: an adipokine with protective features against metabolic syndrome. Iranian Journal of Basic Medical Sciences, 18 (5), 430–442.
  24. Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D. et. al. (1992). Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet, 340 (8828), 1111–1115. doi: http://doi.org/10.1016/0140-6736(92)93147-f

Downloads

Published

2020-09-30

How to Cite

Diachenko, H., & Volkova, Y. (2020). Dynamics of leptin, insulin resistance, parathyroid hormone, 25(OH)D in the implementation of the eras-protocol in patients of surgical profile. ScienceRise: Medical Science, (5 (38), 15–23. https://doi.org/10.15587/2519-4798.2020.213824

Issue

No. 5 (38) (2020)

Section

Medical Science

License

Copyright (c) 2020 Hlib Diachenko, Yuliya Volkova

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.